Literature DB >> 793377

Agglutination with O antisera of salmonella exposed to antibiotics.

V Lorian, B Atkinson, W H Ewing.   

Abstract

Five strains of Salmonella were grown on agar containing subinhibitory concentrations of ampicillin, gentamicin, tetracycline, or chloramphenicol, and on drug-free agar (control). Antigens were prepared by heating bacteria suspensions in saline solution at 100 C or by suspension in alcohol. Antigens were tested for agglutinability with somatic O antisera and fluorescent antibody staining. The alcohol-treated antigens prepared from organisms grown in the presence of antibiotics other than ampicillin had lower agglutination titers than did the control grown on drug-free agar. Heat-treated control antigens had lower agglutination titers than did the alcohol-treated control antigens. The agglutinability of heat-treated antigens prepared from organisms that had been exposed to antibiotics was preserved or enhanced. The agglutinated filaments produced a flocculent sediment, in contrast to the granular sediment of the controls. No significant morphologic abnormality in cell-wall structures of antibiotic-exposed cells could be detected by either electron microscopy or the fluorescent antibody staining.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 793377     DOI: 10.1093/ajcp/66.6.1004

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Interaction of beta-lactam antibiotics with the bactericidal activity of leukocytes against Escherichia coli.

Authors:  A Dalhoff
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

2.  Subinhibitory concentrations of antibiotics alter fibronectin binding to Staphylococcus aureus.

Authors:  R A Proctor; P J Olbrantz; D F Mosher
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

3.  Non-specific influence of antibiotics on the course of infectious processes.

Authors:  G Gillissen
Journal:  Infection       Date:  1982       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.